Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Immunobiology|February 1, 2006
Could single-nucleotide polymorphisms (SNPs) affecting the tumour necrosis factor promoter be considered as part of rheumatoid arthritis evolution?Juan C Aguillón, Andrea Cruzat, Octavio Aravena, et al.
Clinical & Developmental Immunology|July 3, 2013
Dexamethasone preconditioning improves the response of collagen-induced arthritis to treatment with short-term lipopolysaccharide-stimulated collagen-loaded dendritic cellsCorina Peña, David Gárate, Juan Contreras-Levicoy, et al.
Arthritis Research & Therapy|January 21, 2017
TIM-1 defines a human regulatory B cell population that is altered in frequency and function in systemic sclerosis patientsOctavio Aravena, Ashley Ferrier, Madhvi Menon, et al.
Frontiers in Immunology|May 17, 2021
Immunosuppressive Mechanisms of Regulatory B CellsDiego Catalán, Miguel Andrés Mansilla, Ashley Ferrier, et al.
European Cytokine Network|September 8, 2007
Inflammation, synovial angiogenesis and chondroid apoptosis in the evolution of type II collagen-induced arthritisCarlos González, Paula Abello, Raquel Cepeda, et al.
Arthritis Research & Therapy|April 20, 2010
B cells from rheumatoid arthritis patients show important alterations in the expression of CD86 and FcgammaRIIb, which are modulated by anti-tumor necrosis factor therapyDiego Catalán, Octavio Aravena, Francisca Sabugo, et al.
Immunological Reviews|September 28, 2019
Regulatory B cells: Development, phenotypes, functions, and role in transplantationRowa Y Alhabbab, Estefanía Nova-Lamperti, Octavio Aravena, et al.
European Cytokine Network|June 28, 2007
Short-term lipopolysaccharide stimulation induces differentiation of murine bone marrow-derived dendritic cells into a tolerogenic phenotypeLorena Salazar, Octavio Aravena, Juan Contreras-Levicoy, et al.
Clinical Rheumatology|January 15, 2011
The presence of anti-citrullinated protein antibodies (ACPA) does not affect the clinical response to adalimumab in a group of RA patients with the tumor necrosis factor (TNF) α-308 G/G promoter polymorphismLilian Soto, Francisca Sabugo, Diego Catalan, et al.
Frontiers in Immunology|October 21, 2015
Systemic Sclerosis Patients Present Alterations in the Expression of Molecules Involved in B-Cell RegulationLilian Soto, Ashley Ferrier, Octavio Aravena, et al.
Pageof 2